BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 27521287)

  • 1. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
    Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
    Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
    Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
    Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
    Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways.
    Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
    BMC Complement Altern Med; 2014 May; 14():156. PubMed ID: 24886259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
    Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
    Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
    J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
    Yang J; Kan M; Wu GY
    Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
    Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
    BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
    Ndisang JF; Jadhav A
    Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
    Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
    Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
    Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
    J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.
    Xie X; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2012 Oct; 362(1-2):183-93. PubMed ID: 22732364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
    Zhang H; Yang Y; Wang Y; Wang B; Li R
    Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-κB.
    Du M; Hu X; Kou L; Zhang B; Zhang C
    Biomed Res Int; 2016; 2016():3140290. PubMed ID: 27200371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications.
    Noh H; Yu MR; Kim HJ; Lee JH; Park BW; Wu IH; Matsumoto M; King GL
    Kidney Int; 2017 Jul; 92(1):101-113. PubMed ID: 28396116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.